Keertan Dheda

Development of a human respiratory tract effector cell-mediated antiviral assay using blood and airway immune cells from individuals previously hospitalised with COVID-19

Abstract Serum antibody–based neutralisation assays correlate with protective immunity to SARS-CoV-2, but cell-mediated in vitro cytotoxicity assays are lacking. Data on virus-specific respiratory tract immune responses in humans remain limited. Fifteen healthy participants who h...